In brains of people with AD, NCAM2 levels are reduced in hippocampal synapses and the levels of soluble NCAM2 are elevated suggesting increased shedding of NCAM2 from synaptic membranes (Leshchyns’ka et al., 2015). The gene discussed is NCAM2; the disease is Alzheimer disease.